Implant Survival After Insertion of Bone Level Tapered (BLT) Implant Ø 2.9 mm in the Clinical Practice Setting

Inclusion Criteria: * Patients must have voluntarily signed the Informed Consent Form before any study related procedures are performed, are willing and able to attend scheduled follow-up visits and agree that the pseudonymized data are collected and analyzed. * Patients must be males or females who are a minimum of 18 years of age. * Patients with a minimum of 4 weeks history of edentulism in the study area, minimal interdental space and in need of a single tooth replacement with a dental implant central and lateral incisors in the mandible and lateral incisors in the maxilla (Federation Dentaire Internationale (FDI) positions 12, 22, 31, 32, 41 or 42). * Presence of natural tooth or implants adjacent to the study implant position (single tooth gap). * Patients with complete soft tissue coverage of the socket at implant placement. Exclusion Criteria: * Patients with inadequate bone volume and / or quality or metabolic bone disorder. * Patients with local root remnants. * Patients with inadequate wound healing capacity. * Patients with not completed maxillary and mandibular growth. * Patients with serious internal medical problems, uncontrolled bleeding disorders, psychoses, prolonged therapy-resistant functional disorders, xerostomia, weakened immune system, illnesses requiring periodic use of steroids or uncontrollable endocrine disorders. * Patients with poor general state of health. * Patients with drug or alcohol abuse. * Patients with allergies or hypersensitivity to chemical ingredients of titanium-zirconium alloy. * Patients with conditions or circumstances, in the opinion of the Investigator, which would prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance or unreliability. * A woman who is pregnant or planning to become pregnant at any point during the study duration.